Submission of Matters to a Vote of Security Holders.
Happiness Development Group Limited (the "Company") held an extraordinary meeting of shareholders at 9:30 a.m. EST on October 7, 2022 at its principal executive offices in Fujian, China. Shareholders of Class A and Class B ordinary shares voted by proxy or at the meeting. There were 38,412,221 ordinary shares voted, representing approximately 48.56% of the total 79,099,683 outstanding ordinary shares and therefore constituting a quorum of more than one third of the shares outstanding and entitled to vote at the meeting as of the record date of September 2, 2022. Each Class A ordinary share is entitled to one vote, and each Class B ordinary share is entitled to twenty votes. The final voting results for each matter submitted to a vote of shareholders at the meeting are as follows:
1. | That the following constitutes the number of votes voted with respect to the proposal of a share consolidation (or a reverse stock split) of all classes of the Company's ordinary shares at a ratio of one-for-twenty: |
For | Against | Abstain | ||
263,956,012 | 3,289,314 | 23,795 |
Accordingly, the share consolidation has been approved and adopted.
2. | That the following constitutes the number of shares voted with respect to the proposal of increase the Company's authorized share capital to $5,000,000 divided into 350,000,000 Class A ordinary shares, par value $0.01 each, 100,000,000 Class B ordinary shares, par value $0.01 each, and 50,000,000 preferred shares, par value $0.01 each |
For | Against | Abstain | ||
263,457,918 | 3,775,024 | 36,179 |
Accordingly, the increase of the authorized share capital has been approved and adopted.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Happiness Biotech Group Ltd. published this content on 11 October 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 October 2022 13:01:05 UTC.